Neogenomics paid its 7 named executives $32.1M in total in FY2025 (Dec). CEO Tony Zook was paid $9.1M of that.
Pay$100 in the stock at the end of FY22 → $127
Pay of each named executive
Tony ZookDirector and Chief Executive Officer
| FY2025 (Dec) | |||||||
| FY2024 (Dec) | Not disclosed | ||||||
| FY2023 (Dec) | Not disclosed |
3 years
Warren StoneChief Commercial Officer
| FY2025 (Dec) | |||||||
| FY2024 (Dec) | |||||||
| FY2023 (Dec) | |||||||
| FY2022 (Dec) | Not disclosed | ||||||
| FY2021 (Dec) | Not disclosed |
5 years
Jeffrey ShermanChief Financial Officer
| FY2025 (Dec) | |||||||
| FY2024 (Dec) | |||||||
| FY2023 (Dec) | |||||||
| FY2022 (Dec) | Not disclosed | ||||||
| FY2021 (Dec) | Not disclosed |
5 years
Christopher SmithFormer Director and Former Chief Executive Officer
| FY2025 (Dec) | |||||||
| FY2024 (Dec) | |||||||
| FY2023 (Dec) | |||||||
| FY2022 (Dec) | Not disclosed | ||||||
| FY2021 (Dec) | Not disclosed |
5 years
Melody HarrisFormer Chief Operations Officer and Former President, Oncology Data Solutions
| FY2025 (Dec) | |||||||
| FY2024 (Dec) | |||||||
| FY2023 (Dec) | |||||||
| FY2022 (Dec) | Not disclosed | ||||||
| FY2021 (Dec) | Not disclosed |
5 years
Alicia OlivoExecutive Vice President, General Counsel and Business Development
| FY2025 (Dec) | |||||||
| FY2024 (Dec) | |||||||
| FY2023 (Dec) | Not disclosed | ||||||
| FY2022 (Dec) | Not disclosed |
4 years
Gary PassmanChief Culture Officer
| FY2025 (Dec) | |||||||
| FY2024 (Dec) | Not disclosed | ||||||
| FY2023 (Dec) | Not disclosed |
3 years
CEO pay against the pay peers
In FY2025 (Dec), the median CEO pay of the 8 peers with pay on file was $9.1M. CEO pay of Neogenomics for that year is not on file.
- 1Natera
- 2Medpace Holdings
- 3QuidelOrtho
- 4AtriCure
- 5Adaptive Biotechnologies
- 6Veracyte
- 7CareDx
- 810x Genomics
- 9NeogenomicsThis companyNot disclosed
- 10Emergent BioSolutions, Inc.Not disclosed
- 11Exact Sciences CorporationNot disclosed
- 12Fulgent Genetics, Inc.Not disclosed
- 13Guardant HealthNot disclosed
- 14Maravai Life Sciences Holdings, Inc.Not disclosed
- 15Myriad Genetics, IncNot disclosed
- 16OPKO Health, Inc.Not disclosed
- 17iRhythm Technologies, Inc.Not disclosed
Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.